Sharekhan

Suraksha Diagnostic Ltd

Fri 21/11/2025,15:59:55 | NSE : SURAKSHA

₹ 299.55-1.70 (-0.56%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 302.80

Previous Close

₹ 301.25

Volume

14208

Mkt Cap ( Rs. Cr)

₹1560.08

High

₹ 305.95

Low

₹ 298.00

52 Week High

₹ 449.00

52 Week Low

₹ 231.00

Book Value Per Share

₹ 38.25

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

299.55

88

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

88

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Nov 2025, 3:27PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    14 Nov 2025, 3:23PM Please find the enclosed transcript of the Earnings Call held on Tuesday, 11 November 2025
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Nov 2025, 5:13PM Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
  • Suraksha Diagnostic - Copy of Newspaper Publication

    11 Nov 2025, 12:21PM Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of unaudited (standalone and consolidated) financial results
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    11 Nov 2025, 5:11PM The audio recording of the Earnings Call held today, i.e. Tuesday, 11 November 2025 at 2.00 pm on the interaction of the\r\nCompany's representative w
  • Suraksha Diagnostic - Press Release

    10 Nov 2025, 6:46PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated November 10, 2025, titled ""Press release in respect of unaudite
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    10 Nov 2025, 5:55PM Press release in respect of unaudited (standalone and consolidated ) financial results of the Company for the quarter and six months ended 30 Septembe
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    10 Nov 2025, 5:10PM Investor presentation on the unaudited (Standalone and Consolidated) financial results of the Company for the quarter and six months ended 30 Septembe
  • Suraksha Diagnostic - Investor Presentation

    10 Nov 2025, 5:05PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Financial Results Of The Company For The Quarter And Six Months Ended 30 September 2025

    10 Nov 2025, 4:58PM Financial Results of the Company for the quarter and six months ended 30th September 2025 along with the Limited Review Report.
  • Suraksha Diagnostic Q2 net profit down 12.93% at Rs 9.36 cr

    10 Nov 2025, 4:52PM The company reported standalone net profit of Rs 9.36 crore for the quarter ended September 30, 2025 as compared to Rs 10.75 crore in the same period
  • Suraksha Diagnostic - Outcome of Board Meeting

    10 Nov 2025, 4:41PM Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
  • Suraksha Diagnostic - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Monday, 10 November 2025

    10 Nov 2025, 4:38PM We wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e. on Monday, 10 November 2025, has inter alia, conside
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Nov 2025, 3:56PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 Nov 2025, 3:49PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conf
  • Suraksha Diagnostic - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Oblig

    3 Nov 2025, 9:49AM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    11 Oct 2025, 10:31PM As of September 2025, 48.98% is owned by Indian Promoters and 51.02% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Suraksha Diagnostic - Credit Rating- Revision

    9 Oct 2025, 11:06AM Suraksha Diagnostic Limited has informed the Exchange about Credit Rating- Revision
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Oct 2025, 11:03AM Suraksha Diagnostic Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 20
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Credit Rating

    9 Oct 2025, 10:58AM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Credit Rating Migration
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Oct 2025, 10:48AM Submission of Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Trading Window

    22 Sep 2025, 1:23PM Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Sep 2025, 6:06PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you of the schedule of the An
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Sep 2025, 6:03PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Shareholders meeting

    8 Sep 2025, 5:01PM Suraksha Diagnostic Limited has submitted the Exchange a copy Srutinizers report and consolidated voting result of Annual General Meeting held on Sep
  • Suraksha Diagnostic - Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat

    4 Sep 2025, 9:13PM Clarification on AGM Resolution

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 220.1374 189.5015 170.6301 169.0335
Liabilities 220.1374 189.5015 170.6301 169.0335
Equity 10.4162 6.9 6.9 6.9
Gross Profit 82.5903 71.1917 44.9867 47.5072
Net Profit 33.44 24.3839 7.189 23.751
Cash From Operating Activities 62.798 61.23 44.9253 42.3306
NPM(%) 13.42 11.15 3.78 10.64
Revenue 249.0954 218.5247 189.9854 223.1925
Expenses 166.5051 147.333 144.9987 175.6853
ROE(%) 16.78 12.24 3.6 11.92

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 787.00 -1.78 0.00 170.87 301.39 0.64
Lotus Eye Hospital and Institute Ltd 105.60 0.26 330.00 622.64 3.55 0.00
Vaishali Pharma Ltd 9.47 -2.27 0.00 3906.04 3.13 0.00
Astec Lifesciences Ltd 829.00 12.94 0.00 587.17 -604.77 0.00

Company Info

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Read More

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ

The current price of Suraksha Diagnostic Ltd is ₹ 299.55.

The 52-week high for Suraksha Diagnostic Ltd is ₹ 305.95 and the 52-week low is ₹ 298.00.

The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1560.08. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.

The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT